PL3459542T3 - Zastosowanie związku karbaminianu do zapobiegania lub leczenia neuralgii nerwu trójdzielnego - Google Patents
Zastosowanie związku karbaminianu do zapobiegania lub leczenia neuralgii nerwu trójdzielnegoInfo
- Publication number
- PL3459542T3 PL3459542T3 PL17799674T PL17799674T PL3459542T3 PL 3459542 T3 PL3459542 T3 PL 3459542T3 PL 17799674 T PL17799674 T PL 17799674T PL 17799674 T PL17799674 T PL 17799674T PL 3459542 T3 PL3459542 T3 PL 3459542T3
- Authority
- PL
- Poland
- Prior art keywords
- preventing
- trigeminal neuralgia
- carbamate compound
- treating trigeminal
- treating
- Prior art date
Links
- -1 carbamate compound Chemical class 0.000 title 1
- 206010044652 trigeminal neuralgia Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160061386 | 2016-05-19 | ||
| PCT/KR2017/005172 WO2017200317A1 (ko) | 2016-05-19 | 2017-05-18 | 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
| EP17799674.1A EP3459542B1 (en) | 2016-05-19 | 2017-05-18 | Use of carbamate compound for preventing or treating trigeminal neuralgia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3459542T3 true PL3459542T3 (pl) | 2021-12-27 |
Family
ID=60325324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17799674T PL3459542T3 (pl) | 2016-05-19 | 2017-05-18 | Zastosowanie związku karbaminianu do zapobiegania lub leczenia neuralgii nerwu trójdzielnego |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11207295B2 (enExample) |
| EP (1) | EP3459542B1 (enExample) |
| JP (1) | JP6960415B2 (enExample) |
| KR (1) | KR102421013B1 (enExample) |
| CN (1) | CN109310669B (enExample) |
| AU (1) | AU2017267160B2 (enExample) |
| CA (1) | CA3024284C (enExample) |
| DK (1) | DK3459542T3 (enExample) |
| ES (1) | ES2887338T3 (enExample) |
| MX (1) | MX389613B (enExample) |
| PL (1) | PL3459542T3 (enExample) |
| PT (1) | PT3459542T (enExample) |
| RU (1) | RU2751504C2 (enExample) |
| WO (1) | WO2017200317A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102635936B1 (ko) | 2016-12-14 | 2024-02-13 | 에스케이바이오팜 주식회사 | 탈수초성 질환의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
| JP7408643B2 (ja) * | 2018-09-21 | 2024-01-05 | エスケー バイオファーマスティカルズ カンパニー リミテッド | カルバメート化合物及びそれを含む製剤の急性ストレス障害又は心的外傷後ストレス障害の予防、軽減又は治療のための使用 |
| WO2020080866A1 (ko) * | 2018-10-19 | 2020-04-23 | 에스케이바이오팜 주식회사 | 카바메이트 화합물의 당뇨병성 말초 신경병증 또는 화학요법 유발 말초 신경병증의 예방, 완화 또는 치료를 위한 용도 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3415840A (en) * | 1965-10-22 | 1968-12-10 | American Home Prod | Pyrazole-1-ethanol derivatives |
| DE2628420A1 (de) * | 1976-06-24 | 1978-01-05 | Bayer Ag | 1-acyloxy-2-imidazolyl-1-phenyl- aethane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und nematizide |
| SK57899A3 (en) * | 1996-12-31 | 2000-05-16 | Guilford Pharm Inc | N-linked ureas and carbamates of heterocyclic thioesters |
| RU2283106C2 (ru) * | 2001-02-27 | 2006-09-10 | Орто-Макнейл Фармасьютикал, Инк. | Производные карбаматов для использования для лечения боли |
| US7598279B2 (en) | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| JP4227121B2 (ja) * | 2005-06-08 | 2009-02-18 | 独立行政法人科学技術振興機構 | 神経因性疼痛治療剤 |
| CN102803233B (zh) * | 2009-06-22 | 2017-03-01 | 爱思开生物制药株式会社 | 制备氨基甲酸(r)‑1‑芳基‑2‑四唑基‑乙酯的方法 |
| US8404461B2 (en) * | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| CA2817290A1 (en) * | 2010-11-11 | 2012-05-18 | Josef Penninger | Compounds and methods for treating pain |
| MA39448B1 (fr) * | 2014-05-09 | 2019-12-31 | Tecnimede Sociedade Tecnico Medicinal S | (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical |
-
2017
- 2017-05-16 KR KR1020170060713A patent/KR102421013B1/ko active Active
- 2017-05-18 CA CA3024284A patent/CA3024284C/en active Active
- 2017-05-18 EP EP17799674.1A patent/EP3459542B1/en active Active
- 2017-05-18 JP JP2018560617A patent/JP6960415B2/ja active Active
- 2017-05-18 MX MX2018014081A patent/MX389613B/es unknown
- 2017-05-18 ES ES17799674T patent/ES2887338T3/es active Active
- 2017-05-18 WO PCT/KR2017/005172 patent/WO2017200317A1/ko not_active Ceased
- 2017-05-18 PL PL17799674T patent/PL3459542T3/pl unknown
- 2017-05-18 RU RU2018144784A patent/RU2751504C2/ru active
- 2017-05-18 US US16/302,860 patent/US11207295B2/en active Active
- 2017-05-18 PT PT177996741T patent/PT3459542T/pt unknown
- 2017-05-18 AU AU2017267160A patent/AU2017267160B2/en active Active
- 2017-05-18 CN CN201780030912.5A patent/CN109310669B/zh active Active
- 2017-05-18 DK DK17799674.1T patent/DK3459542T3/da active
-
2021
- 2021-12-02 US US17/457,308 patent/US20220087976A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR102421013B1 (ko) | 2022-07-14 |
| CA3024284A1 (en) | 2017-11-23 |
| US11207295B2 (en) | 2021-12-28 |
| AU2017267160B2 (en) | 2022-11-10 |
| RU2018144784A (ru) | 2020-06-19 |
| JP2019516722A (ja) | 2019-06-20 |
| US20220087976A1 (en) | 2022-03-24 |
| DK3459542T3 (da) | 2021-09-13 |
| RU2751504C2 (ru) | 2021-07-14 |
| CN109310669B (zh) | 2022-02-22 |
| WO2017200317A1 (ko) | 2017-11-23 |
| BR112018073556A2 (pt) | 2019-03-19 |
| CN109310669A (zh) | 2019-02-05 |
| AU2017267160A1 (en) | 2018-12-13 |
| EP3459542A1 (en) | 2019-03-27 |
| JP6960415B2 (ja) | 2021-11-05 |
| US20190175555A1 (en) | 2019-06-13 |
| RU2018144784A3 (enExample) | 2020-08-11 |
| MX2018014081A (es) | 2019-09-02 |
| PT3459542T (pt) | 2021-08-24 |
| EP3459542B1 (en) | 2021-06-30 |
| ES2887338T3 (es) | 2021-12-22 |
| CA3024284C (en) | 2024-01-23 |
| MX389613B (es) | 2025-03-20 |
| EP3459542A4 (en) | 2020-01-08 |
| KR20170131241A (ko) | 2017-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL298381B2 (en) | Menin–MLL interaction inhibitors | |
| GB2555517B (en) | Mitigation of return-oriented programming attacks | |
| PT3109223T (pt) | Mistura para o tratamento de fertilizantes contendo ureia | |
| PL3436444T3 (pl) | Związek heterocykliczny | |
| PT3498693T (pt) | Composto heterocíclico | |
| PT3348557T (pt) | Imidazo[1,2a]piridinas para o tratamento ou prevenção de hiperuricemia ou gota | |
| IL267199A (en) | A method for treating epilepsy | |
| SG11201708793SA (en) | Crystals of azabicyclic compound | |
| PL3459543T3 (pl) | Związek karbaminianowy do zapobiegania lub leczenia fibromialgii | |
| ZA201704116B (en) | 2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2h-pyrrol-5-amine compound inhibitors of beta-secretase | |
| IL256109A (en) | Methods for the treatment or prevention of protopathy | |
| SI3661510T1 (sl) | Postopki zdravljenja vedenjskih sprememb | |
| ZA202103106B (en) | Heterocyclic compounds for the treatment of epilepsy | |
| PL3459542T3 (pl) | Zastosowanie związku karbaminianu do zapobiegania lub leczenia neuralgii nerwu trójdzielnego | |
| LT3424930T (lt) | Junginio, turinčio jak slopinantį aktyvumą, kristalas | |
| IL274979A (en) | Methods for the prevention and treatment of neurogenic seizures | |
| IL274084A (en) | Comb for the treatment of dandruff | |
| IL262916A (en) | Treatment of side effects resulting from chemo-nervous disorder | |
| PT3097082T (pt) | Processos para a síntese de composto de ureia substituída | |
| IL266099A (en) | Heterocyclic composition | |
| PT3661510T (pt) | Métodos de tratamento de alterações do comportamento | |
| GB201701928D0 (en) | Compounds for the treatment of hyperglycaemia |